Home Stock

Stock Research: Zydus

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Zydus

NSEI:CADILAHC INE010B01027
15
  • Value
    74
  • Growth
    5
  • Safety
    Safety
    48
  • Combined
    23
  • Sentiment
    20
  • 360° View
    360° View
    15
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Zydus Lifesciences Limited is an India-based global life sciences company focused on discovering, developing, manufacturing, and marketing healthcare therapies. Its main businesses include integrated pharmaceutical operations, active pharmaceutical ingredients (API), human formulations, animal health and veterinary products, and health and wellness products, with products like Lipaglyn and Ujvira. The company has a global presence, marketing products in the United States, India, Europe, and emerging markets. In the last fiscal year, the company had a market cap of $11341 million, profits of $1978 million, and revenue of $2720 million.

more
Strongest Rank Capital Growth
Weakest Rank Value
Country India
Industry Pharmaceuticals
Size Medium
Website zyduslife.comzyduslife
Index
Good Governace Growth Markets
Zydus stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 67 67 75
Growth
5 41 35 19
Safety
Safety
48 79 49 47
Sentiment
20 83 88 26
360° View
360° View
15 93 82 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
20 23 38 13
Opinions Change
49 81 48 49
Pro Holdings
n/a 85 99 94
Market Pulse
41 92 79 15
Sentiment
20 83 88 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 67 67 75
Growth
5 41 35 19
Safety Safety
48 79 49 47
Combined
23 87 55 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
72 73 68 74
Price vs. Earnings (P/E)
62 50 61 70
Price vs. Book (P/B)
61 58 69 69
Dividend Yield
53 44 45 52
Value
74 67 67 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
21 18 20 22
Profit Growth
21 67 67 39
Capital Growth
4 31 12 66
Stock Returns
43 57 89 23
Growth
5 41 35 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
44 74 62 42
Refinancing
51 44 52 62
Liquidity
66 80 48 39
Safety Safety
48 79 49 47

Similar Stocks

Discover high‑ranked alternatives to Zydus and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews